Sale by Romano Sarah of 1977 shares of First Wave

FWBIDelisted Stock  USD 0.61  0.03  4.69%   
Under 61% of FWBI Old's investor base is looking to short. The analysis of current outlook of investing in FWBI Old suggests that many traders are alarmed regarding FWBI Old's prospects. FWBI Old's investing sentiment shows overall attitude of investors towards FWBI Old.
  
Filed transaction by First Wave Biopharma Inc officer. General open market or private sale of non-derivative or derivative security

Read at macroaxis.com
First insider trading alert for sale of common stock by Romano Sarah, Chief Financial Officer, on 5th of July 2023. This event was filed by First Wave Biopharma Inc with SEC on 2023-07-05. Statement of changes in beneficial ownership - SEC Form 4

FWBI Old Fundamental Analysis

We analyze FWBI Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FWBI Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FWBI Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

FWBI Old is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

FWBI Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with FWBI Old stock to make a market-neutral strategy. Peer analysis of FWBI Old could also be used in its relative valuation, which is a method of valuing FWBI Old by comparing valuation metrics with similar companies.

Peers

FWBI Old Related Equities

IMMXImmix Biopharma   1.32   
8.0%
ICULMF Acquisition   2.93   
19.0%
ZVSAZyVersa Therapeutics   4.07   
26.0%
REVBRevelation Biosciences   4.92   
32.0%
QNRXQuoin Pharmaceuticals   6.06   
40.0%
PHIOPhio Pharmaceuticals   6.63   
43.0%
DRMADermata Therapeutics   7.35   
48.0%
XFORX4 Pharmaceuticals   8.57   
56.0%
ZURAZura Bio   9.96   
65.0%
SONNSonnet Biotherapeutics   12.92   
85.0%
CDIOCardio Diagnostics   15.12   
100.0%
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in FWBI Stock

If you are still planning to invest in FWBI Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FWBI Old's history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation